メディシノバ・インク
MediciNova IncUSUSDMediciNova Inc (US:MNOV) — Biotechnology: Pharmaceutical Preparations. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 2. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
Über das Unternehmen
- Website
- medicinova.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hauptsitz
- LA JOLLA, United States
- CEO
- Yuichi Iwaki
- Mitarbeiter
- 6
- Ausstehende Aktien
- Streubesitz
- 42.94 Mio.
- Marktkapitalisierung
- 74.82 Mio. USD
- Insider
- 2.86%
- Institutionelle Anleger
- 20.38%
- Branche (SIC)
- Pharmaceutical Preparations
- FCF
- −9.12 Mio. USD
- Schulden
- 0 USDNettoliquidität
- Gewinne und FCF – für die 12 Monate bis 30.06.2026 (aktueller Bericht des Unternehmens).
Beschreibung
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Neuigkeiten diese Woche
Noch keine Nachrichten von der Website des Unternehmens.
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Essex Woodlands Manageme… | 2.25% | 1.11 Mio. | 2026-06-30 |
| Blackrock Inc. | 1.53% | 752 091 | 2026-06-30 |
| Citigroup Inc. | 1.29% | 635 715 | 2026-06-30 |
| Vanguard Capital Managem… | 1.24% | 609 052 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.24% | 609 052 | 2026-06-30 |
| Geode Capital Management… | 1.1% | 539 312 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.57% | 282 608 | 2026-06-30 |
| Fidelity Concord Street… | 0.51% | 251 205 | 2026-07-31 |
| UBS Group AG | 0.45% | 222 200 | 2026-06-30 |
| Renaissance Technologies… | 0.42% | 205 400 | 2026-06-30 |
| State Street Corporation | 0.39% | 193 698 | 2026-06-30 |
| iShares Trust-iShares Mi… | 0.32% | 157 930 | 2026-08-31 |
| Northern Trust Corporati… | 0.29% | 143 665 | 2026-06-30 |
| Fidelity Concord Street… | 0.18% | 87 575 | 2026-07-31 |
| SCHWAB CAPITAL TRUST-Sch… | 0.15% | 71 506 | 2026-07-31 |
| Fidelity Concord Street… | 0.14% | 68 406 | 2026-07-31 |
| Fidelity Concord Street… | 0.05% | 24 533 | 2026-07-31 |
| Northern Funds-SMALL CAP… | 0.03% | 13 894 | 2026-06-30 |
| EQ Advisors Trust-1290 V… | 0.02% | 10 525 | 2026-06-30 |
| LINCOLN Varbl INSURANCE… | 0.01% | 6 693 | 2026-06-30 |
| 3D INVESTMENT PARTNERS P… | — | — | 2026-09-25 |
